The allergic rhinitis treatment market is expected to be approximately US $ 17,863.6 million with a healthy CAGR of 3.6% by 2027, the increasing prevalence of allergic rhinitis is expected to propel the growth of the global market

0

A common nasal disorder with nasal itching, sneezing, rhinorrhea, and nasal congestion is allergic rhinitis. Exaggerated responses to pain (hyperalgesia), pressure, pain (allodynia) and hyposmia are some of the other symptoms of the disease. The global allergic rhinitis treatment market is estimated to be $ 13,950.7 million and that $ 17,863.6 million must be reached by 2027.

Get Your FREE Copy of Allergic Rhinitis Treatment Market Report 2021

Conductors

The increasing prevalence of allergic rhinitis is expected to drive the growth of the global allergic rhinitis market over the forecast period. For example, the United States recorded 5.2 million and 19.2 million cases of hay fever in children aged 18 and under and people aged 18 and over, respectively, in 2018, according to the Centers for Disease Control and Prevention (CDC).

In addition, increasing rates of patient self-medication and the availability of over-the-counter drugs are also believed to increase the demand for treatment for allergic rhinitis.

Constraints

The lack of a potential cure is expected to limit the growth of the global rhinitis treatment market. However, antihistamine drugs and nasal sprays help to minimize the impact of the disease.

In addition, the symptoms of allergic rhinitis may correspond to other illnesses or medical problems that may restrict the expansion of the market.

Request Sample PDF Copy of Allergic Rhinitis Treatment Market Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1201

Opportunities

For companies around the world allergic rhinitis treatment market, the high prevalence of asthma should offer lucrative growth opportunities. According to the Global Asthma Report 2018, around 300 million people worldwide have asthma, and that number is expected to reach 100 million by 2025.

In addition, R&D on allergic rhinitis is expected to contribute to market expansion. For example, Glenmark Pharmaceuticals revealed in May 2019 that a Phase 3 study of Ryaltris, an investigational fixed-composition nasal spray for the treatment of seasonal allergic rhinitis, showed positive results.

The global allergic rhinitis treatment market was worth US $ 13,450.3 million in 2019 and is expected to reach US $ 17,863.6 million by 2027, growing at a CAGR of 3.6% between 2020 and 2027.

Key points to remember

New drugs to improve the quality of sleep in patients with allergic rhinitis are being researched and developed on the market. For example, ALK presented a new analysis of clinical trial data in February 2019 revealing that its sublingual allergic immunotherapy pill for the treatment of house dust mite allergies (HDM) can significantly improve the quality of sleep in patients with rhinitis. allergic.

In order to increase their market share, the major players in the sector are focusing on building alliances. For example, Glenmark Specialty SA, a subsidiary of Glenmark Pharmaceuticals Ltd. based in Switzerland, entered into an exclusive licensing agreement with Hikma Pharmaceuticals PLC in February 2020 for the commercialization of its new Ryaltris nasal spray for the treatment of allergic rhinitis in the United States.

Buy this premium report now to grow your business: https://www.coherentmarketinsights.com/insight/buy-now/1201

Reasons to buy this report

• Current and future outlook of the global allergic rhinitis treatment market in developed and emerging markets
• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.
• Regions / countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies used by the main market players

“Limited time offer”

Access an in-depth study with over 150 pages, a list of tables and figures, profiling over 20 companies.
We also offer 15% FREE customization of reports.
Get this premium report with an instant discount of US $ 2000 @ https://www.coherentmarketinsights.com/promo/buynow/1201

Competitive landscape

Leading companies working in the global allergic rhinitis treatment market include, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Merck & Co., ALK, Glenmark Pharmaceuticals Ltd., Mylan, Alcon (Novartis AG), GlaxoSmithKline PLC, Sanofi SA, Unichem Laboratories and Innovus Pharmaceuticals, Inc.

Key developments

To develop their product portfolio, the main players in the industry are focusing on the approval and launch of new treatments. For example, ALK completed the marketing authorization process in 17 European countries for its sublingual allergy immunotherapy pill ITULAZAX in June 2019.

Likewise, Mylan unveiled Dymista, a new type of therapy for allergic rhinitis, in Malaysia in November 2018.

See the press release for more information

Contents

  1. Research objective and hypothesis
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market Snapshot
    • Description of the report
      • Definition and scope of the market
    • Abstract
      • Market extract, by type of treatment
      • Market extract, by administration
      • Market extract, by distribution channel
    • Coherent Opportunity Map (COM)
  3. Analysis of market dynamics, regulations and trends
    • Market dynamics
      • Conductors
      • Constraints
      • Market opportunities
    • Impact analysis
    • Key developments
    • Regulatory scenario
    • PEST analysis
    • COVID-19 impact assessment
  4. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2019-2027 (Million US $)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Year-on-year growth analysis, 2017-2027
      • Segment trends
    • Immunotherapy
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
      • Segment trends
    • Antihistamines
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
      • Segment trends
    • Decongestants
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
      • Segment trends
    • Leukotriene receptor antagonists
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
      • Segment trends
    • Corticosteroids
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
      • Segment trends
  5. Global Allergic Rhinitis Treatment Market, By Administration, 2019-2027 (Million US $)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Year-on-year growth analysis, 2017-2027
      • Segment trends
    • Oral
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Nasal
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Intraocular
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Intravenous
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
  6. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2019-2027 (Million US $)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Year-on-year growth analysis, 2017-2027
      • Segment trends
    • Retail pharmacies
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Hospital pharmacies
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • E-commerce
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
  7. Global Allergic Rhinitis Treatment Market, By Regions, 2019-2027 (Million US $)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Year-on-year growth analysis, 2017-2027
      • Segment trends
    • North America
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Europe
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
        • UK
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • The rest of europe
    • Asia Pacific
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia-Pacific
    • Latin America
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
        • CCG
        • Israel
        • Rest of the Middle East
    • Africa
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
        • North Africa
        • central Africa
        • South Africa
  8. Competitive landscape
  9. Section
    • The references
    • Research methodology
    • About us and commercial contact

Other exclusive reports:

Immunosuppressive Drugs for Organ Transplantation Market

Morphine, Buprenorphine and Other Drugs Market

Pain Management Therapeutics Market

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients of all backgrounds, from Fortune 500 companies to nonprofits and startups looking to enter the market. We excel in providing unmatched actionable market insights across various industry verticals including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.

To learn more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837


Source link

Leave A Reply

Your email address will not be published.